bcl-2 Alters the Antigen-Driven Selection of B Cells in μκ but Not in μ-Only Xid Transgenic Mice

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1054-1061

  Kenny, James J ^a,f   Fischer, Randy T ^b   Lustig, Ana ^a   Dintzis, Howard ^c   Katsumata, Makoto ^d   Reed, John C ^e   Longo, Dan L ^f  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BURNHAM INSTITUTE   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; ONCOPROTEIN; PHOSPHORYLCHOLINE; PROTEIN BCL 2; THYMUS INDEPENDENT ANTIGEN;

ANIMAL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSIOLOGY; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CLONAL DELETION; FEMALE; FLOW CYTOMETRY; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHENOTYPE; PHOSPHORYLCHOLINE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, IGE; SPLEEN;

EID: 0030209818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Osmond, D. G. 1986. Population dynamics of bone marrow B lymphocytes. Immunol. Rev. 93:103.
2. Melchers, F., H. Karasuyama, D. Haasner, S. Bauer, A. Kudo, N. Sakaguchi, B. Jameson, and A. Rolink. 1993. The surrogate light chain in B-cell development. Immunol. Today 14:60.
3. Papavasiliou, F., Z. Misulovin, H. Suh, and M. C. Nussenzweig. 1995. The role of Igβ in precursor B cell transition and allelic exclusion. Science 268:408.
4. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavioe, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H Loblay, K. Raphael, R. J. Trent, and A. Basten. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
5. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371:389.
6. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S.-I. Kumagai, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175:71.
7. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77.
8. Nisitani, S., T. Tsubata, M. Murakami, M. Okamoto, and T. Honjo. 1993. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 178:1247.
9. Strasser, A., S. Whittingham, D. L. Vaux, M. L. Bath, J. M. Adams, S. Cory, and A. W. Harris. 1991. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88:8661.
10. Manz, J., K. Denis, O. Witte, R. Brinster, and U. Storb. 1988. Feedback inhibition of immunoglobulin gene rearrangement by membrane μ, but not by secreted μ heavy chains. J. Exp. Med. 168:1363.
11. Nussenzweig, M. C., A. C. Shaw, E. Sinn, D. B. Danner, K. L. Holmes, H. C. Morse III, and P. Leder. 1987. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin. Science 236:816.
12. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423.
13. Freitas, A., M.-P. Lembezat, and A. Coutinho. 1989. Expression of antibody V-regions is genetically and developmentally controlled and modulated by the B lymphocyte environment. Int. Immunol. 1:342.
14. Gu, H., D. Tarlinton, W. Miller, K. Rajewsky, and I. Forster. 1991. Most peripheral cells in mice are ligand selected. J. Exp. Med. 173:1357.
15. Freitas, A. A., A.-C. Viale, A. Sundblad, C. Huesser, and A. Coutinho. 1991. Normal serum immunoglobulins participate in the selection of peripheral B cell repertoires. Proc. Natl. Acad. Sci. USA 88:5640.
16. Kenny, J. J., C. O'Connell, D. G. Sieckmann, R. T. Fischer, and D. L. Longo. 1991. Selection of antigen-specific, idiotype positive B cells in transgenic mice expressing a rearranged M167-μ heavy chain gene. J. Exp. Med. 174:1189.
17. H gene expression in murine CD5 B cells results from age-dependent cellular selection. Eur. J. Immunol. 21:2017.
18. Arnold, L. W., D. H. Spencer, S. H. Clarke, and G. Haughton. 1993. Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int. Immunol. 5:1365.
19. H12-expressing B cells in the neonate. Eur. J. Immunol. 23:3327.
20. Arnold, L. W., C. A. Pennell, S. K. McCray, and S. H. Clarke. 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179:1585.
21. Hayakawa, K., C. E. Carmack, S. A. Shinton, and R. R. Hardy. 1992. Selection of autoantibody specificities in the Ly-1 B subset. Ann. NY Acad. Sci. 651:346.
22. HCDR3 structures. J. Cell. Biochem. 21A:134 (Abstr. C2-394).
23. Kenny, J. J., A. M. Stall, D. G. Sieckmann, M. C. Lamers, F. Finkleman, L. Finch, and D. L. Longo. 1991. Receptor-mediated elimination of phosphocholine-specific B cells in X-linked immune deficient mice. J. Immunol. 146: 2568.
24. Korsmeyer, S. J. 1992. Bcl-2: a repressor of lymphocyte death. Immunol. Today 13:285.
25. Reed, J. C. 1995. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1.
26. Nunez, G., R. Merino, D. Grillot, and M. Gonzalez-Garcia. 1994. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today 15:582.
27. Merino, R., Y. Ding, D. J. Veis, S. J. Korsmeyer, and G. Nunez. 1994. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13:683.
28. Griffiths, S. D., D. T. Goodhead, S. J. Marsden, E. G. Wright, S. Krajewski, J. C. Reed, S. J. Korsmeyer, and M. Greaves. 1994. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J. Exp. Med. 179:1789.
29. Strasser, A., A. W. Harris, L. M. Corcoran, and S. Cory. 1994. Bcl-2 expression promotes B- but not T-lymphoid development in SCID mice. Nature 368:457.
30. H family repertoire in Bcl-2-Ig transgenic mice. Int. Immunol. 3:1329.
31. Nunez, G., D. Hockenbery, T. J. McDonnell, C. M. Sorensen, and S. J. Korsmeyer. 1991. Bcl-2 maintains B cell memory. Nature 353:71.
32. Smith, K. G. C., U. Weiss, K. Rajewsky, G. J. V. Nossal, and D. M. Tarlinton. 1994. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1:803.
33. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
34. Siegel, R. M., M. Katsumata, T. Miyashita, D. C. Louie, M. I. Greene, and J. C. Reed. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. USA 89:7003.
35. Strasser, A., A. W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 29:889.
36. Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879.
37. Storb, U., C. Pinkert, B. Arp, P. Engler, K. Gollahon, J. Manz, W. Brady, and R. Brinster. 1986. Transgenic mice with μ and κ genes encoding anti-phosphorylcholine antibodies. J. Exp. Med. 164:627.
38. Kenny, I. J., F. Finkleman, F. Macchiarini, W. C. Kopp, U. Storb, and D. L. Longo. 1989. Alteration of the B cell surface phenotype, immune response to phosphocholine and the B cell repertoire in M167 μ plus κ transgenic mice. J. Immunol. 138:1363.
39. L epitopes. Mol. Immunol. 21:961.
40. Sieckmann, D. G., K. Holmes, P. Hornbeck, E. Martin, G. Guelde, S. Bondada, D. L. Longo, and J. J. Kenny. 1994. B cells from M167 μκ transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. J. Immunol. 152: 4873.
41. Kenny, J. J., A. M. Stall, R. T. Fischer, E. Derby, M.-C. W. Yang, P. W. Tucker, and D. L. Longo. 1995. Ig(gamma)2b transgenes promote B cell development but alternate developmental pathways appear to function in different transgenic lines. J. Immunol. 154:5694.
42. Rao, M., W. Lee, and D. Conrad. 1987. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunol. 138:1845.
43. Dintzis, R. Z., M. Okajima, M. H. Middleton, G. Green, and H. M. Dintzis. 1989. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J. Immunol. 143:1239.
44. Spande, T. F. 1980. Synthesis of two novel phosphorylcholine esters for probes in immunological studies. J. Org. Chem. 45:3081.
45. Kenny, J. J., G. Guelde, R. T. Fischer, and D. L. Longo. 1994. Induction of phosphocholine-specific antibodies in X-linked immune deficient mice: in vivo protection against a Streptococcus pneumoniae challenge. Int. Immunol. 6:561.
46. McDonnell, T. J., N. Deane, F. M. Platt G. Nunez, U. Jaeger, J. P. McKearn, and S. J. Korsmeyer. 1989. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79.
47. Scher, I. 1982. CBA/N immune defective mice: evidence for failure of a B cell subpopulation to be expressed. Immunol. Rev. 64:117.
48. - B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J. Immunol. 131:2107.
49. Lynch, R. G., M. Sandor, R. Nunez, A. Mathur, M. Hagen, T. Waldschmidt, B. Van Ness, K. Nelms, N. Noben, A. Ibraghimov, D. Mordue, R. Sacco, P. Teeraratkul, W. T. Schaiff, and L. Iakoubov. 1992. Lymphocyte Fc receptors: the immunobiology and pathology of CD23. Immunobiology 185:235.
50. Rabin, E., C. Ying-zi, and H. H. Wortis. 1992. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages. Ann. NY Acad. Sci. 651:130
51. - B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 3:467.
52. Wortis, H. H., M. Teutsch, M. Higer, J. Zheng, and D. C. Parker. 1995. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl. Acad. Sci. USA 92:3348.
53. McDonnell, T. J., G. Nunez, F. M. Platt, D. Hockenberry, L. London, J. P. McKearn, and S. J. Korsmeyer. 1990. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol. 10:1901.
54. Lang, J., R. Yawger, D. Russel, and D. Nemazee. 1996. Abrogation of tolerance in mature transgenic B-cells by overexpression of the bcl-2 protooncogene. In Proceedings of the Keystone Symposium on Molecular and Cellular Biology. Lymphocyte Activation (Abstr. 3050).
55. Hornbeck, P., and W. E. Paul. 1988. Anti-immunoglobulin and phorbol ester induce phosphorylation of proteins associated with the plasma membrane and cytoskeleton in murine B lymphocytes. J. Biol. Chem. 261:14817.
56. Khan, E. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathburn, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, F. S. Rosen, and P. Sideras. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.
57. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed. 1995. Cloning and functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279.
58. L and bcl-2, displaces bax and promotes cell death. Cell 80:285.